Genmab — September 2016
-
Fredagsnyhed fra konkurrent: http://www.proinvestor.com/investornyt/387719/genmab-rival-sosaetter-stort-kraeftstudie
-
Studiet vil faktisk være en fordel for Genmab.
-
Jeg er enig TheNote...Det ligner teknisk en klassisk bundvending.
-
Jeg er enig med Beskos denne gang. https://play.borsen.dk/social/57c86599d99b63192e1f2f74
-
PFA perspektiverer: https://play.borsen.dk/social/57c93218d99b63192e1f3028
-
Husk Q&A på Zealand Pharma kl. 15. Spørgsmål er stadig velkommen.
-
synes da Anonymous står godt imod...har været nettokøbere (i det små dog) de sidste dage
-
dog faldet alligevel

-
kan godt være man ikke skal lægge så meget i fald under svag volumen..men alligevel...mange små stød trætter mere end et tungt dybt stød
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind